Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases
Rev. Soc. Bras. Med. Trop
; 46(4): 525-527, Jul-Aug/2013. tab
Article
ي En
| LILACS
| ID: lil-683332
المكتبة المسؤولة:
BR1.1
ABSTRACT
Artemisinin-based combination therapy-resistant malaria is rare in Sub-Saharan Africa. The World Health Organization identifies monitoring and surveillance using day-3 parasitaemia post-treatment as the standard test for identifying suspected artemisinin resistance. We report three cases of early treatment failure due to possible artemisinin-based combination therapy-resistant Plasmodium falciparum malaria. All cases showed adequate clinical and parasitological responses to quinine. This study reveals a need to re-evaluate the quality and efficacy of artemisinin-based combination therapy agents in Nigeria and Sub-Saharan Africa.
Key words
النص الكامل:
1
الفهرس:
LILACS
الموضوع الرئيسي:
Quinine
/
Malaria, Falciparum
/
Artemisinins
/
Antimalarials
نوع الدراسة:
Prognostic_studies
المحددات:
Adult
/
Female
/
Humans
البلد/الأقليم حسب الموضوع:
Africa
اللغة:
En
مجلة:
Rev. Soc. Bras. Med. Trop
موضوع المجلة:
MEDICINA TROPICAL
السنة:
2013
نوع:
Article